DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
1-Year Return
29.14%
This Quarter Return
+6.51%
1 Year Return
+29.14%
3 Year Return
+96.76%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
-$6.51M
(-3.8%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-7.74%
Top 10 Holdings %
Top 10 Hldgs %
30.08%
Holding
78
New
12
Increased
15
Reduced
36
Closed
14
Top Buys
| 1 |
Amazon
AMZN
|
$3.27M |
| 2 |
Netflix
NFLX
|
$2.64M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.55M |
| 4 |
Illumina
ILMN
|
$2.51M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$2.33M |
Top Sells
| 1 |
Biogen
BIIB
|
$3.93M |
| 2 |
Microsoft
MSFT
|
$3.9M |
| 3 |
Intel
INTC
|
$2.78M |
| 4 |
Cummins
CMI
|
$2.23M |
| 5 |
Baidu
BIDU
|
$2.23M |
Sector Composition
| 1 | Healthcare | 36.7% |
| 2 | Financials | 15.6% |
| 3 | Technology | 13.32% |
| 4 | Industrials | 10.12% |
| 5 | Communication Services | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
26
DELISTED
Celgene Corp
CELG
| $2.62M | 1.58% |
22,740
-2,265
| -9% | -$261K |
|
27
Intuit
INTU
$188B
| $2.59M | 1.56% |
26,710
+1,470
| +6% | +$143K |
|
28
Regeneron Pharmaceuticals
REGN
$60.8B
| $2.56M | 1.54% |
5,680
+2,270
| +67% | +$1.02M |
|
|
29
Bristol-Myers Squibb
BMY
$96B
| $2.55M | 1.54% |
+39,575
| New | +$2.55M |
|
|
30
Illumina
ILMN
$15.7B
| $2.51M | 1.51% |
+13,924
| New | +$2.51M |
|
31
Marsh & McLennan
MMC
$100B
| $2.47M | 1.49% |
44,083
-4,430
| -9% | -$249K |
|
32
Texas Instruments
TXN
$171B
| $2.45M | 1.47% |
42,795
-2,860
| -6% | -$164K |
|
|
MON
33
DELISTED
Monsanto Co
MON
| $2.41M | 1.45% |
21,400
-2,220
| -9% | -$250K |
|
34
AbbVie
ABBV
$375B
| $2.35M | 1.42% |
40,215
-1,270
| -3% | -$74.3K |
|
35
HDFC Bank
HDB
$361B
| $2.35M | 1.42% |
79,894
+22,820
| +40% | +$672K |
|
|
AET
36
DELISTED
Aetna Inc
AET
| $2.35M | 1.42% |
22,077
-4,510
| -17% | -$480K |
|
37
Abbott
ABT
$231B
| $2.34M | 1.41% |
50,436
-10,305
| -17% | -$477K |
|
38
Honeywell
HON
$136B
| $2.34M | 1.41% |
23,496
+1,222
| +5% | +$122K |
|
|
39
Jazz Pharmaceuticals
JAZZ
$7.86B
| $2.33M | 1.4% |
+13,496
| New | +$2.33M |
|
|
HAR
40
DELISTED
Harman International Industries
HAR
| $2.32M | 1.4% |
17,350
+4,740
| +38% | +$633K |
|
41
Morgan Stanley
MS
$236B
| $2.32M | 1.39% |
64,860
-35,085
| -35% | -$1.25M |
|
42
Charles Schwab
SCHW
$167B
| $2.22M | 1.34% |
72,895
-5,555
| -7% | -$169K |
|
43
Bausch Health
BHC
$2.72B
| $2.05M | 1.24% |
+10,330
| New | +$2.05M |
|
44
Alphabet (Google) Class C
GOOG
$2.84T
| $1.96M | 1.18% |
71,416
-35,396
| -33% | -$973K |
|
45
Tyson Foods
TSN
$20B
| $1.89M | 1.14% |
49,275
+4,660
| +10% | +$178K |
|
|
HDS
46
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.89M | 1.14% |
60,580
| – | – |
|
|
RCPT
47
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.87M | 1.13% |
+11,365
| New | +$1.87M |
|
48
AstraZeneca
AZN
$253B
| $1.86M | 1.12% |
+54,240
| New | +$1.86M |
|
|
APC
49
DELISTED
Anadarko Petroleum
APC
| $1.65M | 0.99% |
19,916
-2,575
| -11% | -$213K |
|
50
Vertex Pharmaceuticals
VRTX
$102B
| $1.65M | 0.99% |
13,968
+8,215
| +143% | +$969K |
|